Full-Time

Director Business Development

Global Supplements

Pharmavite

Pharmavite

1,001-5,000 employees

Manufactures science-backed vitamin and supplement brands

Compensation Overview

$159k - $265k/yr

+ Annual performance bonus + 401(k) match

No H1B Sponsorship

West Hills, Los Angeles, CA, USA

In Person

Bachelor's, Master's, PhD

Category
Business & Strategy (1)
Required Skills
Supply Chain Management
Financial analysis
Mergers & Acquisitions (M&A)

Get referred to Pharmavite

See people who can refer or advise you

Requirements
  • A bachelor's degree is required.
  • Eight to ten years of progressive experience in business development, corporate development, mergers and acquisitions, licensing, strategic partnerships, finance, or commercial strategy, preferably within supplements, consumer health, nutrition, or wellness.
  • Demonstrated success supporting transactions, partnerships, or expansion initiatives.
  • Strong understanding of the supplements and consumer health landscape, including regulatory and commercial dynamics.
  • Experience operating in cross-functional and matrixed organizations.
  • Experience collaborating with executive leadership teams and external strategic partners.
  • Strong collaboration, project management, and stakeholder alignment skills.
  • Ability to manage multiple workstreams in a fast-paced environment.
  • Strong financial acumen, including valuation modeling and investment analysis.
  • Ability to integrate commercial, scientific, operational, and financial considerations into strategic decision-making.
  • Strong understanding of supplements, consumer health, and healthcare professional engagement models.
  • Ability to evaluate and support complex partnerships and strategic growth initiatives.
  • Ability to operate independently in a lean, fast-moving environment.
Responsibilities
  • Support establishment of business development strategy and execution in alignment with Pharmavite's Global Supplements Platform.
  • Drive strategic expansion through acquisitions, partnerships, licensing, joint ventures, and ecosystem collaborations beginning in the United Kingdom and Europe.
  • Collect market information for supplements with a focus on priority markets.
  • Track, identify, and follow potential acquisition targets in collaboration with the local team and ONCE.
  • Operate as an enterprise leader partnering across Commercial, Research and Development, Operations, Regulatory, Legal, Finance, and Executive Leadership.
  • Lead and coordinate the due diligence process across all functions.
  • Support post-acquisition integration and strategic partnership governance.
  • Provide coordination and collaboration support across global business development initiatives involving the United Kingdom and Europe team and ONCE.
  • Identify, evaluate, and prioritize acquisitions, strategic partnerships, licensing opportunities, joint ventures, and commercial alliances with a focus on the United Kingdom, Europe, and other priority markets globally.
  • Support execution of business development priorities informed by Pharmavite executive leadership and broader global platform objectives.
  • Develop strong external relationships with industry stakeholders, partners, investment bankers, founders, and ecosystem participants.
  • Partner closely with ONCE on end-to-end transaction processes from sourcing, evaluation, and valuation through due diligence and negotiation.
  • Prepare strategic recommendations, investment analyses, and executive-level presentations for governance committees and senior leadership.
  • Coordinate cross-functional diligence across commercial, regulatory, scientific, operational, legal, and finance teams.
  • Support due diligence, integration planning, and execution activities for acquisitions and partnerships.
  • Support Pharmavite's global operating model with a focus on scalability, operational excellence, and strategic alignment.
  • Help coordinate go-to-market partnership opportunities across consumer-led and healthcare professional engagement models.
  • Provide post-acquisition integration and transition support activities to maximize value creation.
  • Support United Kingdom and Europe business development leadership to ensure alignment and coordination across global supplements initiatives and Pharmavite resources in the United States.
  • Partner closely with Pharmavite Executive Leadership and subject matter experts across Research and Development, Regulatory Affairs, Operations, Supply Chain, Finance, Legal, and Commercial teams.
  • Collaborate with ONCE and other Otsuka-affiliated organizations to support successful global supplements platform development.
  • Serve as a strategic advisor on global market trends, competitive activity, and partnership opportunities with a focus on priority markets.
Desired Qualifications
  • An advanced degree such as an MBA, Master of Science, Doctor of Philosophy, or equivalent is preferred in Business, Life Sciences, Nutrition, Healthcare, or a related discipline.
  • Strategic thinking, an entrepreneurial mindset, and strong execution capabilities.
  • Effective communication and influencing across executive and cross-functional teams.
  • Excellent communication, presentation, and stakeholder management skills in global settings.

Pharmavite develops and markets vitamin, mineral, and supplement products to support personal health. Its brands include Nature Made, MegaFood, Nurish by Nature Made, EQUELLE, and Uqora, and the company creates science-backed supplements aimed at filling nutrient gaps and promoting wellness. The products work by providing targeted nutrients in formulations that match consumer needs, with attention to delivery formats and areas such as women’s health, based on ongoing scientific research and partnerships with healthcare professionals. Pharmavite differentiates itself through a long history (dating back to 1971), a broad, trusted portfolio, a focus on quality and science, and collaborations to discover new nutrients and delivery methods. Its goal is to “bring the gift of health to life” by helping people lead healthier lives with effective, trusted supplements. Pharmavite operates as part of Otsuka Pharmaceutical Co., Ltd., and continues to expand its science-backed VMS offerings.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Los Angeles, California

Founded

1971

Get referred to Pharmavite

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Zero Sugar Gummies and March 2026 gut-health launches expand premium, high-frequency supplement occasions.
  • Pharmavite opened New Albany and expanded Opelika, creating manufacturing capacity for growth.
  • Great Place To Work certification in June 2026 supports recruiting and retention in a tight labor market.

What critics are saying

  • Hamzeh v. Pharmavite LLC entered federal court July 7, 2026, threatening expensive product-liability discovery.
  • Lang v. Pharmavite alleges prenatal vitamins contain phthalates and BPA, risking brand damage.
  • If Nature Made loses trust, retailers like Walmart, CVS, and Amazon can squeeze shelf space.

What makes Pharmavite unique

  • Nature Made is Pharmavite's science-backed, No. 1 vitamin brand, still winning retail trust.
  • The $250 million New Albany facility scales gummies to 6 billion annually.
  • Leadership added Dr. Stewart Townsend in R&D, strengthening claims, formulation, and regulatory depth.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Flexible Work Hours

Company News

Pharmavite
Sep 8th, 2025
Pharmavite Names Dr. Stewart Townsend Ph.D. as Senior Vice President, Research and Development

Dr. Townsend joins Pharmavite as Senior Vice President, Research and Development, and will lead Science, R&D and Regulatory Affairs for Nature Made.

Plant Services
May 30th, 2025
Pharmavite opens $250M vitamin manufacturing facility in Ohio

Pharmavite opens $250M vitamin manufacturing facility in Ohio.

The Observer
Mar 4th, 2025
Former mayor honored with renaming of arts center

Pharmavite has announced plans to invest approximately a little more than $13.6 million in the construction of a dietary supplement manufacturing facility which consists of the construction of building additions and the purchase of new manufacturing machinery at its existing facility located within the corporate limits of Opelika.

O-A News
Sep 7th, 2024
Pharmavite invests an additional $12M into its Opelika facility

The City of Opelika and Mayor Gary Fuller announced in August that Pharmavite is investing $12 million for another expansion at its Opelika facility.

PharmiWeb
Jun 19th, 2024
The Rise Of Oral Clinical Nutrition Supplements Market Dynamics And Opportunities 2023-2033

By 2033, the global oral clinical nutrition supplement market is expected to reach US$ 19613.1 million, surpassing US$ 10788.70 million in 2023. A CAGR of 6.2% indicates positive market growth over the forecast period.The rising demand for oral clinical supplements is attributable to a higher focus on maintaining strong immunity. The demand in the oral clinical nutrition supplement market is poised to surge. Its applications in tackling the issue of malnutrition may aid the overall growth of the oral clinical nutrition supplement market.Several oral clinical nutrition supplement manufacturers are introducing new flavors to attract a more consumer base. This may remain one of the key factors spurring growth in the market.Unlock Insights – Request Your Report Sample Today! https://www.futuremarketinsights.com/reports/sample/rep-gb-9486Key Countries Covered: USA, Canada, Brazil, Mexico, Chile, Peru, Germany, UNITED KINGDOM, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey.etcCompetitive Landscape: Top Manufacturers of Oral Clinical Nutrition Supplement Market and their Recent DevelopmentsSome of the key players in the oral clinical nutrition supplement market are: NUTRICIÓN MÉDICA SL, Meiji Holdings Co., Ltd., Medtrition Inc., Baxter International Inc., B. Braun Melsungen AG., Fresenius Kabi AG, Mead Johnson & Company, LLC, Otsuka Holdings Co., Ltd., Abbott Laboratories, Danone Nutricia, Victus, Inc., Cambrooke Therapeutics, Inc., GlaxoSmithKline plc, Nestlé S.A., Kate Farms, Inc., Perrigo Company plc, Sichuan Kelun Pharmaceutical Co., Ltd., AYMES International Ltd., Pfizer Inc., Medifood GmbH, Nature’s Bounty Inc., Pharmavite LLC.Recent DevelopmentThe key players are mainly focusing on strategies that may help them increase their market share and gain a competitive advantage.For instance:PediaSure Harvest and Ensure Harvest products were relaunched in September 2021 with organic ingredients and plant-based protein